PHARMA NEWS, MULT...
Follow
Find
36.1K views | +166 today

5 Reasons Pharma Should Reconsider Instagram

From www.intouchsol.com

More and more, Instagram is becoming a viable social channel for pharma, if used in the right way. So here are five reasons we believe pharmas should take a new look at Instagram.

No comment yet.

«Les pharmas devront participer au financement des traitements les plus chers»

From linkis.com

Selon Patrick Flochel, d’Ernst & Young, l’industrie pharmaceutique devra innover pour faire face à la pression sur les prix
No comment yet.

Pharma Digital Marketing - 5 future trends

From fr.slideshare.net

Digital Marketing within the Pharma Industry:
The first and safer way is to summarize the past 12 months, the second, more dangerous but also more exciting is to predict what will happen in 2015.
For years digital marketing was treated as a fifth wheel in pharma business. Whatever we say, the truth is that those organisations are made of sales force. And a digital sales force was just another marketing gimmick that does not add value but a workload and cost.
However, during past few years this traditional sales force thinking was challenged. Payers pressure forced companies to reduce ranks of sales representatives. Regulatory decisions have limited possibility of sales rep to meet HCPs. The result is that sales rep cannot meet his Client often enough to detail the product and maintain relationship in the same time.
Digital came to help with e-detailing and web-based self-detail solutions. CRM software supports reps with data that allow reps to have a meaningful conversation with HCPs they barely know.
Combining detailing visits with digital tatics and good old direct marketing is our new buzz word: Multi Channel Marketing or Multi Channel Sales
No comment yet.

Health app improves behaviors in recent randomized controlled trial #hcsmeu #hcsmeufr

From www.imedicalapps.com

This article describes a recent randomized controlled trial that supports the hypothesis that lifestyle apps can impact healthy behaviors and potentially health outcomes.
No comment yet.

Accompagner les talents à l'ère du digital

From www.axa.com

Digital Academy #AXA: COOCs, Serious Games,... pour former collaborateurs & distributeurs
Frederic Patry's curator insight, June 1, 4:54 PM

AXA : Impressionante maturité digitale. 

L'Oréal définit les indicateurs clés de sa transformation digitale

From www.larevuedudigital.com

L'Oréal définit actuellement les indicateurs qui vont mesurer sa transformation digitale. Ces KPIs couvrent les trois axes de son plan stratégique. C'est à dire l'accélération du e-commerce, la per...
No comment yet.

Pharma and Healthcare Marketing for Digital Media - Rahul Avasthy

From www.slideshare.net

Ranking the digital competence of pharmaceutical brands
No comment yet.

Pharmaceutical firms wake up to the power of social media #pharma #hcsmeu

From www.prmoment.com

Top pharmaceutical companies are making far more effort to engage audiences on social media claims a report “Connecting the Dots: Which Pharma Companies are Succeeding in the Social Media Space?“ from agency Ogilvy Healthworld. Looking at the pharma companies which are most successful on social sites, the report suggests that in order to engage audiences, firms must be brave and prepared to have honest and meaningful conversations about their brands.

“We know that some pharma companies have been cautious in their approach to social media, but our report clearly demonstrates a dramatic and successful increase in activity,” explains Rebecca Canvin, social media manager at Ogilvy Healthworld, adding: “social media has changed the way pharma companies communicate – it allows them to build corporate reputation and engage in genuine, meaningful conversations with audiences. For companies who want to stand out from the crowd it’s time to be brave, get personal, educate and integrate social media into their wider marketing strategy.”

On one hand, it is surprising that healthcare firms are so keen to use social media, as regulatory boundaries and compliance constraints provide some limitations on what they can say. On the other hand, social media provides the perfect forum to explain about latest health findings, as Canvin says: “People don’t want to wade through hundreds of pages of disease information, but they may be more open to new knowledge on social media … Social media has the potential to revolutionise the way big pharma educates physicians, allowing doctors to obtain the facts they require without the many issues often associated with rep visits or advertising to clinicians.”

Key findings

  • The average number of tweets by pharma has gone up by 530 per cent since 2013 and Twitter followers have increased by nearly 300 per cent
  • The pharma companies with the biggest communities aren’t necessarily the most effective at engaging with their users and generating interest.
  • Followers reward pharma companies who post frequently and engage continuously – those that keep their networks fresh with regular updates have the highest interaction from the community.

Looking at the firms which better communicate on social, it seems that size isn’t everything. Those companies with the most followers don’t always succeed in engaging their audiences. For example, companies Boehringer and Novo Novdisk have community sizes well below the average, yet score highly when it comes to engagement.

What does drive engagement is the amount a company uses social media. Canvin explains: “It isn’t hard to understand why the most active companies are the ones enjoying the most engagement – after all, social media in its very nature demands participation and interaction. And, of course, any conversation is a two-way street. The increase in involvement that we saw in 2014 is not just because pharma companies are becoming more active, but because their audiences are also showing a little more willingness to jump in. Overall, it seems that followers will reward the companies who post frequently and engage continuously – those organisations with high activity scores received more likes and comments on Facebook and more replies from Twitter followers.”

Methodology

The data for the report was gathered by monitoring 10 of the most popular networks for 14 pharma companies across six categories: social presence, social network, community size, activity, engagement and activity. The profile of each company was reviewed for one week per month for three months during 2014 to ensure sufficient data was collected.


No comment yet.

Top 7 Trends in Pharma Marketing for 2015

From bluelatitude.net

Toward the end of 2014, the Blue Latitude team got together to discuss how pharma marketing will change and what trends will be big in pharma marketing in 2015.
No comment yet.

DTC Marketing priorities

From worldofdtcmarketing.com

KEY TAKEAWAY:  While pharma dabbles in mobile apps there are too many other things that DTC marketers should do to ensure they are part of the conversation. According to Comscore there is a fundame...
No comment yet.

So, what do digital natives expect from the industry & how well do we understand this?

From www.epghealthmedia.com

Individual pharma companies, digital/multichannel, brand, marketing and medical teams can safely assume that most HCPs are now digital natives and by 2020, two thirds will be so* This topic formed the focus of several presentations delivered this month in Rome at EXL's @DigitalPharma Europe conference, as demonstrated in the slide below from Antonio Blanco, Area Sales Lead, Astrazeneca. *Source: LBI Health: www.lbi.com/uk
No comment yet.

Less Than One In Five Patients Are Aware Of Services Available To Them, Accenture Survey Finds | Business Wire

From www.businesswire.com

"When patients are aware of therapeutic services, nearly six out of 10 of those surveyed use them (58 percent), and nearly eight in 10 (79 percent) perceive the services as extremely or very valuable, a new survey by Accenture reveals. Yet, less than one in five patients (19 percent) are aware these programs even exist."

No comment yet.

Alerte sur le fléau des mauvais médicaments #hcsmeufr

From www.lemonde.fr

Ces substances mettent en danger les progrès dans la lutte contre le VIH, le paludisme et la tuberculose.
No comment yet.

Diabète: Sanofi mise sur ses nouveaux produits et une offre diversifiée - Le Parisien

From www.leparisien.fr

Nouvelle insuline Toujeo, stylos injecteurs ou lecteurs de glycémie: le groupe pharmaceutique Sanofi mise sur de nouveaux produits lancés cette...
No comment yet.

Scenario planning for engagement in pharmaceutical communication

From engagementstrategy.com

Previously, we looked at the case for ‘agile approvals’ and considered how regulatory constraints provide us with a catalyst for innovation. In this article, we consider how to plan ahead and start preparing for engagement.

No comment yet.

Novartis's 'robotic pill'

From nycity.today

Novartis is collaborating with Rani Therapeutics, a US start-up in an endeavour to produce a so-called ‘robotic pill’ enabling a convenient administration of complex biotech drugs that are otherwise, normally given by injection.


Rani’s capsule looks very much like a conventional pill, and is swallowed in the same way. However, the underlying mechanism of action differs in that the pill contains tiny needles made of sugar that are pushed into the wall of the intestine to deliver the drug.

Pacific Cove's curator insight, May 28, 12:19 PM

Rani’s capsule looks very much like a conventional pill, and is swallowed in the same way. However, the underlying mechanism of action differs in that the pill contains tiny needles made of sugar that are pushed into the wall of the intestine to deliver the drug.  #Seniors #SeniorCare #Drugs #Caregivers #Caregiving

Jerome Leleu's curator insight, May 30, 2:46 AM

ajouter votre perspicacité ...

LEO Pharma lance le site web oncothrombose

From buzz-esante.fr

Le laboratoire LEO Pharma lance un nouveau site web dédié aux patients atteints de cancer et aux professionnels de santé : oncothrombose.fr.
No comment yet.

The Mary Meeker Internet Trends 2015 Report

From techcrunch.com

If your life depends on technology, you better read this cover to cover. Kleiner Perkins partner Mary Meeker's yearly Internet Trends report is the ultimate..
No comment yet.

Le digital : un enjeu majeur du marketing de la santé - Markentive

From www.markentive.fr

Le secteur de la santé est en plein boom digital et il est crucial pour les entreprises du domaine de sérieusement reconsidérer leur stratégie digitale
No comment yet.

What do patients want?

From worldofdtcmarketing.com

KEY TAKEAWAY: There are two things that today's patients' want in health care; empathy and to be heard.  Pharma has to find a way to take a more empathetic approach to DTC marketing if we want our ...
No comment yet.

Patient Engagement is the Blockbuster Drug of the Century

From www.forbes.com

The insight of the year goes to Leonard Kish, a health IT strategy consultant, for making that statement regarding patient engagement. The corollary to this statement is a game changer: What happens when effective patient engagement becomes the Standard of Care? Used to determine whether a doctor is liable [...]
No comment yet.

Pfizer lance la communauté My Hématologie - Buzz-esanté

From buzz-esante.fr

Le laboratoire Pfizer a lancé il y a quelques semaines, en partenariat avec la société Healthme, une communauté dédiée aux hématologues : My Hématologie.
No comment yet.

De Second Life à real life : l'immersion comme vecteur d'expérience #hcsmeufr #pactonco

From fr.slideshare.net

Présentation lors du lancement de la V2 PactOnco de Pfizer sur la réalité virtuelle, la simulation numérique à travers le concept de Metavers...
No comment yet.